In fact, so worried is the HHS Secretary about WiFi, 5G, and other RF radiation that his department is now launching a study ...
Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...
Under the proposed changes, 10 schools will lose some programs of study. Instead, students will have access to 16 courses at ...
Registrational myositis trial actively enrolling with planned 17-patient cohort and 2027 rese-cel BLA submission - including an outpatient dosing option using a single weight-based dose IND amendment ...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...
Abstract: We demonstrate efficient polymer solar cells made from large molecular weight (MW) poly(3-hexylthiophene-2,5-diyl) (P3HT) nanostructures made by nanoimprint lithography (NIL). We found NIL ...
True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...
CAMBRIDGE, Mass. - Ernexa Therapeutics (NASDAQ:ERNA) announced Tuesday the successful completion of its Pre-Investigational New Drug Application meeting with the U.S. Food and Drug Administration for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback